Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535372) titled 'ASO Treatment for Syndromic Craniosynostoses' on April 10.
Study Type: Observational
Primary Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition:
Craniosynostoses
Crouzon Syndrome
Saethre Chotzen Syndrome
Muenke Syndrome
Pfeiffer Syndrome
Apert Syndrome
Intervention:
Genetic: Design of patient specific ASO
Recruitment Status: Not recruiting
Date of First Enrollment: April 20, 2026
Target Sample Size: 12
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT07535372
Disclaimer: Curated by HT Syndication....